Study Title

Neoadjuvant [177Lu]Lu-PSMAI&T Radioligand Therapy (PSMA-RLT) for Patients With Oligometastatic Prostate Cancer Diagnosed Using [68Ga]Ga-PSMA-11 PET Imaging Followed by Radical Prostatectomy: A Prospective Phase II Pilot Study

Study Details

Description:

Prospective single-center phase II study to evaluate the PSA, imaging and pathological response, as well as oncological outcomes of systemic radioligand therapy [177Lu]Lu-PSMAI&T (PSMA-RLT) in patients planned for radical prostatectomy (RP) for oligometastatic prostate cancer (PCa) diagnosed using [68Ga]Ga-PSMA-11 PET examination. Ten patients with oligometastatic primary PCa diagnosed using [68Ga]Ga-PSMA-11 PET-CT/MRI imaging will be included in this study.

Sponsor:

Medical University of Vienna

Contacts:

Sazan Rasul, PhD (Principal Investigator)

sazan.rasul@meduniwien.ac.at

004314040058742

Shahrokh F. Shariat, Professor

shahrokh.shariat@meduniwien.ac.at

004314040026150

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468